1 / 11

High Potency Active Pharmaceutical Ingredients - Future of the Global Industry by 2023

The global HPAPI market is expected to reach USD 26.84 Billion by 2023 from USD 16.49 Billion in 2017, at a CAGR 8.7%. The base year considered for the study is 2017 and the forecast period is from 2018 to 2023.

mmvaidya
Download Presentation

High Potency Active Pharmaceutical Ingredients - Future of the Global Industry by 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MarketsandMarkets Presents High Potency Active Pharmaceutical Ingredients - Future of the Global Industry by 2023 https://www.marketsandmarkets.com/Market-Reports/high-potency-api-market- 36582475.html

  2. The report "High Potency APIs /HPAPI Market by Type (Innovative, Generic), Synthesis (Synthetic, Biotech, moAB, Vaccines, Recombinant Proteins), Manufacturer (Captive and Merchant), Therapy (Oncology, Glaucoma, Hormonal Imbalance) - Global Forecasts to 2023", The global HPAPIs market is expected to reach USD 26.84 Billion by 2023 from USD 17.72 Billion in 2018, at a CAGR 8.7%. Browse: 239 market data tables 42 figures 216 pages And in-depth TOC on ?High Potency APIs /HPAPI Market? Download The PDF Brochure@ https://www.marketsandmarkets.com/pdfdownload.asp?id=36582475 The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine. https://www.marketsandmarkets.com/Market-Reports/high-potency-api-market- 36582475.html

  3. The objectives of this study are as follows:. # To define, describe, and forecast the global HPAPI market on the basis of type, type of manufacturer, type of synthesis, therapeutic application, and region. # To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges) # To strategically analyze micromarkets with respect to the individual growth trends, prospects, and contributions to the overall market # To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players # To forecast the size of the market segments of North America, Europe, Asia, and the Rest of the World (RoW) # To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies https://www.marketsandmarkets.com/Market-Reports/high-potency-api-market- 36582475.html

  4. https://www.marketsandmarkets.com/Market-Reports/high-potency-api-market-https://www.marketsandmarkets.com/Market-Reports/high-potency-api-market- 36582475.html

  5. The innovative HPAPIs segment to dominate the market in 2018 Based on type, the HPAPIs market is segmented into innovative and generic HPAPIs. In 2018, the innovative HPAPIs segment is expected to account for the largest share of the market. The large share can be attributed to the increased investments of innovator companies in R&D, manufacture, marketing, and supply of innovative HPAPIs as the revenue generated from these molecules are considerably high. Talk to Our Research Experts@ https://www.marketsandmarkets.com/speaktoanalyst.asp?id=36582475 Based on type of manufacturer, the captive manufacturers segment to dominate the market in 2018 https://www.marketsandmarkets.com/Market-Reports/high-potency-api-market- 36582475.html

  6. On the basis of type of manufacturer, the HPAPIs market is segmented into captive HPAPI and merchant HPAPI manufacturers. In 2018, the captive HPAPI manufacturers segment is expected to account for the largest share of the market. The large share of this segment is attributed to the preference of innovative companies to maintain in-house manufacturing facilities for economic benefits. The biotech HPAPIs segment is projected to grow at the highest CAGR during the forecast period. On the basis of type of synthesis, the HPAPIs market is categorized into synthetic and biotech HPAPIs. The biotech HPAPIs segment is expected to grow at the highest CAGR during the forecast period. https://www.marketsandmarkets.com/Market-Reports/high-potency-api-market- 36582475.html

  7. Advances in biotechnology, growing demand for antibody-drug conjugates, growing demand due to their specificity in action, their similarity with the natural biological compounds, and significant growth in the demand for monoclonal antibodies are the major factors driving the growth of this market. North America to dominate the HPAPIs market in 2018 In 2018, North America is expected to account for the largest share of the market followed by Europe. Factors such growing incidence of cancer, increasing investments in cancer research, technological advancements in HPAPI manufacturing, growing CMOs market, constructive government reforms like the Patient Protection and Affordable Care Act, growing focus of leading pharmaceutical companies in the HPAPIs segment, and increasing demand for antibody-drug conjugates (ADCs) are responsible for the large share of NA https://www.marketsandmarkets.com/Market-Reports/high-potency-api-market- 36582475.html

  8. The HPAPIs market is fragmented, with the presence of several large as well as emerging players. Prominent players in the HPAPIs market include Pfizer (US), Novartis International AG (Switzerland), Sanofi (France), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (US), Teva (Israel), Eli Lilly and Company (US), Merck (US), AbbVie (US), Mylan (US), and F. Hoffmann-La Roche (Switzerland). Players in this market are adopting various organic and inorganic strategies, such as agreements, collaborations, alliances, and partnerships; mergers and acquisitions; and expansions. https://www.marketsandmarkets.com/Market-Reports/high-potency-api-market- 36582475.html

  9. About MarketsandMarkets™ Marketsa?dMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide co?pa?ies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach Marketsa?dMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at Marketsa?dMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. Marketsa?dMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. Marketsa?dMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. Marketsa?dMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. 36582475.html https://www.marketsandmarkets.com/Market-Reports/high-potency-api-market-

  10. Contact Us Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets

More Related